Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.
Saved in:
| Title: | Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. |
|---|---|
| Authors: | Gettinger, Scott N.1 (AUTHOR) Scott.gettinger@yale.edu, Song, Zihe2 (AUTHOR), Reckamp, Karen L.3 (AUTHOR), Moscow, Jeffrey A.4 (AUTHOR), Gray, Robert J.2 (AUTHOR), Wang, Victoria2 (AUTHOR), McShane, Lisa M.5 (AUTHOR), Rubinstein, Larry V.5 (AUTHOR), Patton, David R.6 (AUTHOR), Williams, P. Mickey7 (AUTHOR), Hamilton, Stanley R.8 (AUTHOR), Kong, Xiao-Tang9 (AUTHOR), Tricoli, James V.10 (AUTHOR), Conley, Barbara A.10 (AUTHOR), Arteaga, Carlos L.11 (AUTHOR), Harris, Lyndsay N.10 (AUTHOR), O'Dwyer, Peter J.12 (AUTHOR), Chen, Alice P.13 (AUTHOR), Flaherty, Keith T.14 (AUTHOR) |
| Source: | JCO Precision Oncology. 12/1/2024, Vol. 8, p1-10. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
